Coombe Women and Infants University Hospital
Dublin, 00000, Ireland
NCT Number: NCT03695588
There is currently a gap in the literature with regards to the utility of the QLB performed in conjunction with intrathecal morphine (ITM) for Caesarean section. The aim of the study is to assess the efficacy of the QLB as part of a multi-modal analgesic approach in patients after caesarean section.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Dublin, 00000, Ireland
Post-operative pain relief management remains challenging after Caesarean-section. The perfect postoperative analgesic regimen is yet to be elucidated, but opioids remain a cornerstone whether they are administered intra-thecally, or systemically or both. Unfortunately, opioids are associated with significant adverse effects such as respiratory depression, post-operative nausea and vomiting (PONV), sedation and pruritus. Therefore, the search for opioid sparing analgesic techniques is important.
The study treatment consists of a quadratus lumborum block (QLB) of either 0.25% Levobupivacaine or a simulated sham QLB after C-section under spinal anaesthesia. The participants will be randomized into one of two groups with an internet based randomisation tool, and then allocated to either group as per the allocation in a sealed opaque envelope.
Spinal anaesthesia will be performed in a standardised manner using 10-15mg hyperbaric bupivacaine, 20ug fentanyl and 100ug preservative free morphine. Anaesthetic and surgical management will be conducted as per the usual manner. Diclofenac 100mg suppositories and IV Paracetamol 1g will be administered at the end of surgery. A Morphine PCA will be connected to the patient in the recovery room after the intervention.
The bilateral posterior QLB will be performed after surgery in the supine position in an aseptic manner. The patient will be blinded to the group intervention as the sterile drapes will be left hanging blocking the patient's view of the procedure. The block from the spinal anaesthetic will mean the patient is unaware of the procedure being carried out. A curvilinear ultrasound probe will be used to identify the quadratus lumborum muscle.
Intervention group:
Aseptic, ultrasound guided, bilateral QLB using a posterior approach. This is known as the QLB 2 approach. A maximum volume of 20 ml of 0.25% Levobupivacaine will be administered each side. After the procedure a sterile dressing will be placed on the puncture site.
Placebo group:
The patient will be sterilized, draped and scanned in the same manner as the intervention group, until the target injection point is identified. The operator will use a blunt needle to apply pressure to the skin, (without breaking the skin), for one minute as if they are performing the procedure. This will be performed bilaterally. After the procedure, a sterile dressing will be placed over the pressure area.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ultrasound guided Quadratus Lumborum block using a posterior approach. (QLB 2)
Sham QLB - Ultrasound identification of QLB followed by skin pressure with blunt needle.
Time frame: 24 hours
Intravenous PCA (patient controlled analgesia) morphine consumption up to 24 hours.
Time frame: 6, 12, 24, 48 hours
VAS (visual analogue scale) pain scores at rest - lying supine in bed.
Time frame: 6, 12, 24, 48 hours
VAS pain scores on movement - raising head and shoulders off pillow when lying supine in bed.
Time frame: 24, 48 hours
The incidence of N+V requiring rescue anti-emetics.
Time frame: 24 hours
Intravenous PCA (patient controlled analgesia) morphine bolus demands up to 24 hours.
Time frame: 48 hours
Total opioid consumption at 48 hours - converted to IV morphine equivalents.
Time frame: 24, 48 hours
Quality of Recovery questionnaire.
Time frame: 24, 48 hours
Quality of Recovery questionnaire.
Coombe Women and Infants University Hospital
Other
Quadratus Lumborum Block (QLB) for Pain Relief After Caesarean Section: A Prospective, Double-blind, Randomised Controlled Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07286799
Agnosia, Nervous System Diseases
Istanbul, Şişli, Turkey (Türkiye)
View Trial DetailsNCT05822492
Agnosia, Analgesia
Samsun, Turkey (Türkiye)
View Trial DetailsNCT05713643
Agnosia, Analgesia
Tanta, ElGharbiaa, Egypt
View Trial DetailsNCT03199170
Agnosia, Analgesia
Bangkok, Thailand
View Trial Details